Trial Search Results

Listening to Mom 2: Neural, Clinical and Language Outcomes

The purpose of this study is to examine whether playing recordings of a mother's voice to her infant while in the hospital nursery is an effective treatment for promoting healthy brain and language development in infants born preterm.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Stanford Investigator(s):

Intervention(s):

  • Behavioral: Language Treatment
  • Behavioral: Control Treatment

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Infants born preterm at Stanford Children's Hospital between 24 0/7 - 31 6/7 weeks
   gestational age

Exclusion Criteria:

   - Congenital anomalies

   - Recognizable malformation syndromes

   - Active seizure disorders

   - History of Central Nervous System infections

   - Hydrocephalus

   - Major sensori-neural hearing loss

   - Likelihood to be transferred from NICU to alternate care facility or home environment
   prior to 36 weeks PMA and/or brain MRI scan

   - Intraventricular Hemorrhage Grades III-IV

   - Cystic periventricular leukomalacia (PVL)

   - Surgical treatment for necrotizing enterocolitis

   - Small for gestational age (SGA) <3 percentile and/or Intra-uterine growth restriction
   (IUGR) no head sparing

   - Twin-to-twin transfusions

Ages Eligible for Study

24 Weeks - 31 Weeks

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Katherine E Travis, PhD
650-498-2576
Recruiting